ABBV: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/e97206aa-df1d-4241-84ee-de8959ca6cd9/","filing_uuid":"e97206aa-df1d-4241-84ee-de8959ca6cd9","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/e97206aa-df1d-4241-84ee-de8959ca6cd9/print/","filing_document_content_type":"text/html","income":null,"expenses":"1050000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Neil Cohen","dt_posted":"2026-10-20T15:35:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1399 New York Avenue NW","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401049961,"url":"https://lda.gov/api/v1/registrants/401049961/","house_registrant_id":null,"name":"ABBVIE, INC.","description":"Biopharmaceutical company","address_1":"1399 New York Avenue NW","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DANIEL BACHNER","contact_telephone":"+1 202-383-9616","dt_updated":"2026-08-03T09:35:22.017305-04:00"},"client":{"id":197319,"url":"https://lda.gov/api/v1/clients/197319/","client_id":12,"name":"ABBVIE INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-25"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act H.R. 8630, The Protecting Equal Access to Thyroid Act of 2026 Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy Issues related to FDA communications","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 Public Law No: 119-21 (formerly known as H.R. 1, One Big Beautiful Bill Act) Implementation Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Issues related to antitrust and competition policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to pharmaceutic tariffs and unfair trade practices Issues related to U.S. biotech competitiveness with China","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}